<li>alfentanil<p>alfentanil, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>amiodarone<p>amiodarone and paroxetine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>amitriptyline<p>paroxetine and amitriptyline both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>amoxapine<p>paroxetine and amoxapine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>apixaban<p>paroxetine and apixaban both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>aripiprazole<p>paroxetine will increase the level or effect of aripiprazole by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>arsenic trioxide<p>arsenic trioxide and paroxetine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>astemizole<p>astemizole and paroxetine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>bupropion<p>bupropion will increase the level or effect of paroxetine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>paroxetine increases toxicity of bupropion by unspecified interaction mechanism. Avoid or Use Alternate Drug. May lower seizure threshold; keep bupropion dose as low as possible.</p></li><li>buspirone<p>paroxetine and buspirone both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>carvedilol<p>paroxetine will increase the level or effect of carvedilol by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>chlorpromazine<p>paroxetine will increase the level or effect of chlorpromazine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>cisapride<p>cisapride and paroxetine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>citalopram<p>citalopram and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug. Combination may increase risk of serotonin syndrome or neuroleptic malignant syndrome-like reactions.</p></li><li>clomipramine<p>paroxetine will increase the level or effect of clomipramine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>paroxetine and clomipramine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>cyclobenzaprine<p>paroxetine and cyclobenzaprine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>desipramine<p>paroxetine will increase the level or effect of desipramine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>paroxetine and desipramine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>desvenlafaxine<p>paroxetine and desvenlafaxine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>dextromethorphan<p>paroxetine will increase the level or effect of dextromethorphan by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>paroxetine and dextromethorphan both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>disopyramide<p>disopyramide and paroxetine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>dolasetron<p>dolasetron, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>dosulepin<p>paroxetine and dosulepin both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>doxepin<p>paroxetine will increase the level or effect of doxepin by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>paroxetine and doxepin both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>duloxetine<p>paroxetine will increase the level or effect of duloxetine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>duloxetine and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>escitalopram<p>escitalopram and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fentanyl<p>fentanyl, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fentanyl intranasal<p>fentanyl intranasal, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fentanyl iontophoretic transdermal system<p>fentanyl iontophoretic transdermal system, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fentanyl transdermal<p>fentanyl transdermal, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fentanyl transmucosal<p>fentanyl transmucosal, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>flecainide<p>paroxetine will increase the level or effect of flecainide by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>fluoxetine<p>fluoxetine will increase the level or effect of paroxetine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>fluoxetine and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fluphenazine<p>paroxetine will increase the level or effect of fluphenazine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>fluphenazine and paroxetine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>fluvoxamine<p>paroxetine will increase the level or effect of fluvoxamine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>fluvoxamine and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>granisetron<p>granisetron, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>haloperidol<p>paroxetine will increase the level or effect of haloperidol by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>hydrocodone<p>paroxetine will increase the level or effect of hydrocodone by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>hydromorphone<p>paroxetine will increase the level or effect of hydromorphone by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>hydromorphone, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>ibutilide<p>ibutilide and paroxetine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>iloperidone<p>paroxetine will increase the level or effect of iloperidone by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>imipramine<p>paroxetine will increase the level or effect of imipramine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>paroxetine and imipramine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>indapamide<p>indapamide and paroxetine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>levomilnacipran<p>levomilnacipran and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>linezolid<p>linezolid and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug. Linezolid may increase serotonin as a result of MAO-A inhibition. If linezolid must be administered, discontinue serotonergic drug immediately and monitor for CNS toxicity. Serotonergic therapy may be resumed 24 hours after last linezolid dose or after 2 weeks of monitoring, whichever comes first.</p></li><li>lofepramine<p>paroxetine will increase the level or effect of lofepramine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>paroxetine and lofepramine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>lorcaserin<p>paroxetine and lorcaserin both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>maprotiline<p>paroxetine and maprotiline both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>mefloquine<p>mefloquine increases toxicity of paroxetine by QTc interval. Avoid or Use Alternate Drug. Mefloquine may enhance the QTc prolonging effect of high risk QTc prolonging agents.</p></li><li>meperidine<p>paroxetine and meperidine both increase  serotonin levels. Avoid or Use Alternate Drug.<span><br><br></span>meperidine, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>methamphetamine<p>paroxetine will increase the level or effect of methamphetamine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>methylene blue<p>methylene blue and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug. Methylene blue may increase serotonin as a result of MAO-A inhibition. If methylene blue must be administered, discontinue serotonergic drug immediately and monitor for CNS toxicity. Serotonergic therapy may be resumed 24 hours after last methylene blue dose or after 2 weeks of monitoring, whichever comes first.</p></li><li>metoclopramide<p>metoclopramide and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug. Additive effects; increased risk for serotonin syndrome, neuroleptic malignant syndrome, dystonia, or other extrapyramidal reactions</p></li><li>metoprolol<p>paroxetine will increase the level or effect of metoprolol by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>mexiletine<p>paroxetine will increase the level or effect of mexiletine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>mianserin<p>paroxetine and mianserin both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>mibefradil<p>paroxetine will increase the level or effect of mibefradil by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>milnacipran<p>milnacipran and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>morphine<p>paroxetine will increase the level or effect of morphine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>morphine, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>nebivolol<p>paroxetine will increase the level or effect of nebivolol by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>nefazodone<p>nefazodone and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>netupitant/palonosetron<p>netupitant/palonosetron, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>nortriptyline<p>paroxetine will increase the level or effect of nortriptyline by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>paroxetine and nortriptyline both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>ondansetron<p>ondansetron, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>oxycodone<p>paroxetine will increase the level or effect of oxycodone by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>oxymorphone<p>paroxetine will increase the level or effect of oxymorphone by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>palonosetron<p>palonosetron, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>pentamidine<p>paroxetine and pentamidine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>perphenazine<p>paroxetine will increase the level or effect of perphenazine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>perphenazine will increase the level or effect of paroxetine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>perphenazine and paroxetine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>phentermine<p>paroxetine, phentermine.
Either increases toxicity of the other by Mechanism: unknown. Avoid or Use Alternate Drug. Risk of serotonin syndrome.</p></li><li>procainamide<p>paroxetine and procainamide both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>promethazine<p>paroxetine will increase the level or effect of promethazine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>propafenone<p>paroxetine will increase the level or effect of propafenone by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>propafenone will increase the level or effect of paroxetine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug. Monitor heart rate and EKG in patients receiving concurrent paroxetine and propafenone. Doses may need to be reduced. </p></li><li>propranolol<p>paroxetine will increase the level or effect of propranolol by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>protriptyline<p>paroxetine and protriptyline both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>quinidine<p>quinidine and paroxetine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>rasagiline<p>rasagiline and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug. Severe CNS toxicity associated with hyperpyrexia has been reported with the combined treatment of an antidepressant and rasagiline. Avoid combination within 14 days of MAOI use.</p></li><li>remifentanil<p>remifentanil, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>selegiline transdermal<p>selegiline transdermal and paroxetine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>sertindole<p>paroxetine will increase the level or effect of sertindole by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>sertraline<p>sertraline will increase the level or effect of paroxetine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>paroxetine and sertraline both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>sotalol<p>paroxetine and sotalol both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>st john's wort<p>paroxetine and st john's wort both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>sufentanil<p>sufentanil, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>sufentanil sl<p>sufentanil sl, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>tedizolid<p>tedizolid, paroxetine.
Either increases effects of the other by Mechanism: pharmacodynamic synergism. Avoid or Use Alternate Drug. both increase serotonin levels; increased risk of serotonin syndrome.</p></li><li>terfenadine<p>paroxetine and terfenadine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>thioridazine<p>paroxetine will increase the level or effect of thioridazine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>thioridazine will increase the level or effect of paroxetine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>thioridazine and paroxetine both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>timolol<p>paroxetine will increase the level or effect of timolol by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>tipranavir<p>tipranavir will increase the level or effect of paroxetine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>tolterodine<p>paroxetine will increase the level or effect of tolterodine by  affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug.</p></li><li>trazodone<p>paroxetine and trazodone both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>trimipramine<p>paroxetine and trimipramine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>venlafaxine<p>paroxetine and venlafaxine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>vilazodone<p>paroxetine, vilazodone.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug. Concomitant therapy should be discontinued immediately if signs or symptoms of serotonin syndrome emerge and supportive symptomatic treatment should be initiated.  .</p></li><li>vortioxetine<p>paroxetine increases toxicity of vortioxetine by serotonin levels. Avoid or Use Alternate Drug.<span><br><br></span>paroxetine increases levels of vortioxetine by affecting hepatic enzyme CYP2D6 metabolism. Avoid or Use Alternate Drug. Decrease vortioxetine dose by 50% when coadministered with strong CYP2D6 inhibitors.</p></li><li>warfarin<p>paroxetine increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li>